期刊文献+

29例胃肠道间质瘤临床病理分析 被引量:1

A clinicopathologic study of 29 cases of gastrointestinal stromal tumors
下载PDF
导出
摘要 目的 探讨胃肠道间质瘤的临床病理 ,免疫组化和组织分型。方法  2 9例胃肠道间质瘤进行常规检查及免疫组化染色检测。结果 胃肠道间质瘤好发于胃和小肠 ,常见的临床症状为消化道出血 ,腹痛。 2 9例中Vimentin ,SMA ,S 10 0 ,CD3 4 阳性分别为 96 5 % ,4 1 3% ,17 2 % ,86 2 %。结论 胃肠道间质瘤虽然光镜下形态相似 ,但具有多向分化特征 ,免疫组化在诊断中起重要作用 ,CD3 4 有较高特异性和敏感性。 Aim To investigate the clinicopathologic,immunohistochemical and histologic classification of gastrointestinal stromal tumors (GISTs).Methods 29 cases of GISTs were studied by routine stain and immunohistochemisty.Results GISTs affect predominantly the stomach and small intestines .The main clinical manifestations were gastrointestinal hemorrhage and abdominal pain. In 29 cases of GISTs,the positive rates by immunohistochemical methods for Vimentin,SMA,S-100,and CD 34 were 96.5%,41.3%,17.2%,86.2% respectively.Conclusion Despite their similar light microscopic appearance.GISTs have multiple differentiated characteristic.Immunohistochemisty play a main role in the diagnosis of GISTs,whereas CD 34 has relatively high specificity and sensitivity.
作者 郑铭 江淑萍
出处 《安徽医药》 CAS 2004年第6期440-441,共2页 Anhui Medical and Pharmaceutical Journal
关键词 胃肠道间质瘤 临床病理 免疫组化 CD34 gastrointestinal stromal tumors(GISTs) clinicopathology immunohistochemisty CD 34
  • 相关文献

参考文献6

  • 1[1]Lewin KJ, Riddel RH, Weinstein WM et al. Gastrointestinal pathology and its clinical implications[J]. New York;Igakushion,1992;284- 341.
  • 2[2]Miettinen M, Sarlomo-rikala M, Lasota J. Gastrointestinal stromal tumors recent advances in understanding of their biology [J]. Hum Pathol, 1999 ;30:1213 - 20.
  • 3[3]Rosai J, Ackemen LV et al. Ackman s surgical pathology [J]. Se.Louis :Mosby, 1996:645 - 7.
  • 4[5]Van de Rijn M, Hendrickson HD, Rouse RV. CD34 expresssion by gastrointestinal stromal tumors [J]. Hum Pathol, 1994; 25 ( 8 ): 766-9.
  • 5[6]Erlandson RA, Klimstra DS, Woodruff JM. Subclassification of gastrointestinal stromal tumors based on evolution by electron microscopy and immunohistochemisty[J]. Ultratruct pathol, 1996 ;20: 373 -93.
  • 6[7]Demetri GD. yon Mehren M, Blanke CD et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors[J]. N Engl J Med,2002 ;347:472 - 80.

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部